Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Yamuna Devi, Bakthavatchalam"'
Autor:
Yamuna Devi Bakthavatchalam, Dhanalakshmi Solaimalai, Anand Ashok, Harthi Ragothaman, Soniya Krishnamoorthy, Nivedhana Subburaju, Sanjay bhattacharya, Rudresh Sm, Shripad Murlidhar Taklikar, Barney Isaac, Kamini Walia, Balaji Veeraraghavan
Publikováno v:
Clinical Epidemiology and Global Health, Vol 28, Iss , Pp 101510- (2024)
Background: Piperacillin/tazobactam has limited activity against Enterobacterales, which concurrently express ESBL/ampC/OXA-1 beta-lactamases, which are widely prevalent in India. Thus, there is a severe dearth for carbapenem sparing options that agg
Externí odkaz:
https://doaj.org/article/837fb71facf348c9b8d22166f876cc8b
Autor:
Ramya Juliet, Archana Loganathan, Ayyanraj Neeravi, Yamuna Devi Bakthavatchalam, Balaji Veeraraghavan, Prasanth Manohar, Ramesh Nachimuthu
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
The emergence of multi-drug resistance in Salmonella, causing food-borne infections, is a significant issue. With over 2,600 serovars in in Salmonella sp., it is crucial to identify specific solutions for each serovar. Phage therapy serves as an alte
Externí odkaz:
https://doaj.org/article/bf993ea7e03a4e809e95695fe1e19640
Autor:
Dilip Dubey, Manish Roy, Tajamul H. Shah, Noor Bano, Vidushi Kulshrestha, Sandeep Mitra, Pushpender Sangwan, Madhulika Dubey, Ali Imran, Bhawna Jain, Aravind Velmurugan, Yamuna Devi Bakthavatchalam, Balaji Veeraraghavan
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 22, Iss 1, Pp 1-6 (2023)
Abstract Infections in critically-ill patients caused by extensively-drug-resistant (XDR)-Pseudomonas aeruginosa are challenging to manage due to paucity of effective treatment options. Cefepime/zidebactam, which is currently in global Phase 3 clinic
Externí odkaz:
https://doaj.org/article/508cd9903a834312bc0d7a2a8fd97068
Autor:
Yamuna Devi Bakthavatchalam, Yuvasri Manokaran, Dhanalakshmi Venkatesan, Karthik Gunasekaran, Abi Manesh, Barney Isaac, Binesh Lal, John Jude Antony Prakash, Kamini Walia, Balaji Veeraraghavan
Publikováno v:
Clinical Epidemiology and Global Health, Vol 26, Iss , Pp 101431- (2024)
Background and objective: Eradication of Burkholderia pseudomallei infections requires prolonged antibiotic treatment indicating microbiological and pharmacokinetic limitations of current options. Methods and results: Levonadifloxacin, a novel benzoq
Externí odkaz:
https://doaj.org/article/41dec1e800ee4200acb2ef56939a186a
Autor:
Saranya Vijayakumar, Rayapadi G. Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Balaji Veeraraghavan, Anand Anbarasu
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTColistin resistance in Acinetobacter baumannii is mediated by multiple mechanisms. Recently, mutations within pmrABC two-component system and overexpression of eptA gene due to upstream insertion of ISAba1 have been shown to play a major role
Externí odkaz:
https://doaj.org/article/62bbe26bb6b64c6fa855971e05f79c82
Autor:
Yamuna Devi Bakthavatchalam, Fiza Abdullah, Devishree Srinivasan, Ayyanraj Neeravi, Rani Diana Sahni, Abi Manesh, Balaji Veeraraghavan
Publikováno v:
Clinical Epidemiology and Global Health, Vol 25, Iss , Pp 101417- (2024)
Background: Beta-lactamase expressing Enterobacterales are challenging to treat. The potency of aminoglycosides as a bactericidal agent has increased interest in using them in combination regimens. In the present study, we evaluated the in-vitro acti
Externí odkaz:
https://doaj.org/article/9bc34728f99e43459bfd60fa9b552ccc
Autor:
Andrea M. Hujer, Steven H. Marshall, Andrew R. Mack, Kristine M. Hujer, Yamuna Devi Bakthavatchalam, Kushal Umarkar, Snehal R. Palwe, Swapna Takalkar, Prashant R. Joshi, Rahul Shrivastava, Hariharan Periasamy, Sachin S. Bhagwat, Mahesh V. Patel, Balaji Veeraraghavan, Robert A. Bonomo
Publikováno v:
mBio, Vol 14, Iss 6 (2023)
ABSTRACTMulti-drug resistant (MDR) Pseudomonas aeruginosa harbor a complex array of β-lactamases and non-enzymatic resistance mechanisms. In this study, the activity of a β-lactam/β-lactam-enhancer, cefepime/zidebactam, and novel β-lactam/β-lact
Externí odkaz:
https://doaj.org/article/89cbc21d5db4415483462f4e8fa03ecc
Autor:
Dhiviya Prabaa Muthuirulandi Sethuvel, Yamuna Devi Bakthavatchalam, Maruthan Karthik, Madhumathi Irulappan, Rahul Shrivastava, Hariharan Periasamy, Balaji Veeraraghavan
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 3, Pp 829-841 (2023)
Abstract Bacteria acquire β-lactam resistance through a multitude of mechanisms among which production of β-lactamases (enzymes that hydrolyze β-lactams) is the most common, especially in Gram-negatives. Structural changes in the high-molecular-we
Externí odkaz:
https://doaj.org/article/b762f3cd6f254fc9a2016e579bab37d7
Autor:
Yamuna Devi Bakthavatchalam, Mamta Puraswani, Abel Livingston, Monisha Priya, Dhanalakshmi Venkatesan, Divya Sharma, Ramya Iyadurai, Kishore Pichamuthu, Balaji Veeraraghavan, Purva Mathur
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 168-172 (2022)
ABSTRACT: Objectives: The genetic basis for the spread of vancomycin resistance in Enterococcus faecium is largely unexplored in India. The present study aimed to investigate the plasmid diversity and variation of Tn1546 associated with vanA harbouri
Externí odkaz:
https://doaj.org/article/e14f31c1aa38437c840464d33f3aa4db
Autor:
Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Priyanka Babu, Ayyan Raj Neeravi, Vignesh Narasiman, Balaji Veeraraghavan
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 331-336 (2021)
ABSTRACT: Objectives: Linezolid resistance in Enterococcus faecium is emerging worldwide. In this study, we aimed to characterise two linezolid-resistant E. faecium isolates using whole-genome sequencing. Methods: Antimicrobial susceptibility testing
Externí odkaz:
https://doaj.org/article/b7e207fcc6bd46aba1f941a586abc2a6